Viz.ai’s Post

Uncover the Brain-Heart Connection Complex post-acute stroke referral pathways can delay AFib diagnosis and lead to patients being lost to follow-up. With Viz Connect®, Cardiology and Neurology can collaborate in real-time to make informed treatment decisions and reduce secondary stroke risk. To learn more about this transformative solution, book a meeting with Viz.ai at HRX or stop by Xchange Address #532. https://bit.ly/3AvZxAN

Dive into the January 2024 S:VIN Journal! Stroke: Vascular and Interventional Neurology is a fully Open Access bi-monthly journal aimed primarily at reporting clinical, translational and basic sciences research on interventional, endovascular, medical and surgical management of stroke and vascular disease of the brain, spinal cord, and head and neck. https://lnkd.in/ghp-sqit

Navigating the complexities of the post-acute stroke care pathway can often times be challenging, especially for patients with suspected AFib. Hear from Jonathan Hsu, MD, MAS, FACC, FAHA, FHRS on how he utilized Viz Connect to streamline communication between neurology and cardiology to ensure the optimal delivery of patient care at UCSD. Learn more about Viz Connect here: https://lnkd.in/gm8caQ75

The May 2024 S:VIN Journal is now available! Access it here: https://lnkd.in/gJ9wqUSy Stroke: Vascular and Interventional Neurology is a fully Open Access bi-monthly journal aimed primarily at reporting clinical, translational and basic sciences research on interventional, endovascular, medical and surgical management of stroke and vascular disease of the brain, spinal cord, and head and neck.

#braininjury #radiation #bisdemethoxycurcumin #treatment Treatment of radiation-induced brain injury with bisdemethoxycurcumin https://lnkd.in/gmaQBvBh Radiation therapy is considered the most effective non-surgical treatment for brain tumors. However, there are no available treatments for radiation-induced brain injury. Bisdemethoxycurcumin (BDMC) is a demethoxy derivative of curcumin that has anti-proliferative, anti-inflammatory, and anti-oxidant properties. To determine whether BDMC has the potential to treat radiation-induced brain injury, in this study, we established a rat model of radiation-induced brain injury by administering a single 30-Gy vertical dose of irradiation to the whole brain, followed by intraperitoneal injection of 500 μL of a 100 mg/kg BDMC solution every day for 5 successive weeks. Our results showed that BDMC increased the body weight of rats with radiation-induced brain injury, improved learning and memory, attenuated brain edema, inhibited astrocyte activation, and reduced oxidative stress. These findings suggest that BDMC protects against radiation-induced brain injury.

Check out the latest! The September 2024 S:VIN Journal can be accessed here: https://lnkd.in/g4ScrQpM Stroke: Vascular and Interventional Neurology is a fully Open Access bi-monthly journal aimed primarily at reporting clinical, translational and basic sciences research on interventional, endovascular, medical and surgical management of stroke and vascular disease of the brain, spinal cord, and head and neck.

Dazzling Dilemmas: Differentiating Intracranial Masses Using MR Imaging Melissa van Kuik, M.D.; et al. (Department of Neurology, OLVG, Amsterdam, Netherlands)   It is not uncommon for intracranial space-occupying lesions (SOLs) to be identified during the diagnostic workup in patients with focal neurological deficits. The differential diagnosis of intracranial SOLs includes conditions such as abscesses, hemorrhage, meningiomas, gliomas, lymphomas, and cerebral metastases. The therapeutic approach to these diagnoses varies greatly. Therefore, accurately distinguishing between these conditions is paramount. The authors elaborate on the differentiation between cerebral abscesses, gliomas, and cerebral metastases using different #MRI sequences. Techniques such as DWI and perfusion imaging can provide information about various aspects of the SOL and the adjacent brain tissue, helping to distinguish between these conditions.   In practice, however, these scanning techniques still do not fully guarantee a correct diagnosis. A more detailed analysis of the peritumoral region or the use of other techniques such as MR spectroscopy may potentially lead to further improvement of the accuracy. Learn more at https://lnkd.in/euRbCHks   #magnetomworld #Neuroimaging Siemens Healthineers    Liza Gelissen, M.D. (Amsterdam UMC, Netherlands); Gwendolyn Vuurberg, M.D., Ph.D. (Rijnstate Hospital, Arnhem, Netherlands); Compendium Geneeskunde

DL driven quantitative analysis tools are critical to the value we must deliver in the imaging community

📣 In a new consensus statement published in Annals of Neurology, Scalfari and colleagues (2024) present evidence that current clinical guidelines may not sufficiently focus on the smouldering components of #multiplesclerosis, and that better understanding of smouldering-associated worsening (SAW) may help better track disease progression 🔥 🧠 They propose considering MS in terms of both its inflammatory and smouldering components. At icometrix, we share the authors' vision that the smouldering component of MS may provide much insight into a given patient's disease state, and should be assessed alongside the inflammatory component. Hence, our clinical #icobrain ms report is designed to emphasize the most clinically actionable metrics assessing disease progression in terms of both changes in inflammation and changes in brain volume. Further, our research-use icobrain ms+ report contains additional metrics that may relate to SAW, such as paramagnetic rim lesions, cervical spinal cord surface-area, and volumetrics of additional neural substructures. In this way, using icobrain ms allows clinicians to assess their patients using accurate, validated metrics which are in line with cutting edge clinical recommendations Congratulations on a milestone publication for the MS field Antonio Scalfari, Tony Traboulsee, Jiwon Oh, Laura Airas, Jose Manuel Garcia Dominguez, Cristina Granziera, Benjamin Greenberg, Kerstin Hellwig, Zsolt Illes, Jan Lycke, Veronica Popescu, Francesca Bagnato, Gavin Giovannoni For a link to the paper, see the comment below!

Complex post-acute stroke referral pathways can lead to delays in diagnosis and patients lost to follow-up. With Viz Connect, neurology and cardiology providers can seamlessly coordinate care with real-time referrals using HIPAA-compliant communication. This not only improves patient identification for cardiac monitoring , but also empowers cardiology to reduce secondary stroke risk. Hear more from Jonathan Hsu, MD, MAS, FACC, FAHA, FHRS on how Viz Connect is transforming post-acute stroke care. 🧠❤️ Learn more: https://lnkd.in/eJumjwnX